UPDATE: Vivus Down Nearly 12% After JP Morgan Downgrade on Lackluster Qsymia News

JP Morgan analyst Cory Kasimov downgrades Vivus (NASDAQ: VVUS ) Tuesday morning, lowering rating from Overweight to Neutral, while moving their price target from $15 to $8. The report notes that Qsymia has been on the market for a year and a half without any catalyst or signs of progression,